{
"info": {
"nct_id": "NCT04070976",
"official_title": "Phase II Randomized Controlled Trial of Concomitant Chemoradiotherapy With Standard Fractionation Compared to Hypofractionated Concomitant Chemoradiotherapy Followed by Brachytherapy, for Clinical Stage III Cervical Cancer Patients",
"inclusion_criteria": "* Women over 18 years old\n* Cervical Cancer at IIIA, IIIB y IIIC1 FIGO´s clinical stages\n* Histology: squamous, adenosquamous or adenocarcinoma\n* No previous treatment\n* No distance metastases, discard by Positron Emission Tomography (PET)/CT\n* Functional State ECOG (Eastern Cooperative Oncology Group) 0-2\n* Complete Blood count obtained at least 14 days before admission to the study with adequate bone marrow function defined as:\n* Absolute neutrophil count ≥ 1,500 cell/mm3\n* Platelets ≥ 100,000 cell/mm3\n* Hemoglobin ≥ 10.0 g/dl\n* Leukocyte count ≥ 4000 cell/mm3\n* Adequate Renal Function defined as:\n* Serum Creatinine ≤ 1.5 mg/dl within 14 days before admission to the study\n* Patients with HIV infection (human immunodeficiency virus) must have a CD4 cell count ≥ 350 cells / mm3 measured within 14 days prior to study entry (no HIV test is required)\n* The patient must understand the protocol and provide the specific informed consent of the study before admission\n* Negative pregnancy test\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients who had chemotherapeutic, surgical and/or radiotherapy treatment for female reproductive tract pathologies\n* Previous invasive neoplasia (except non-melanoma skin cancer) unless there is complete remission of the disease of 3 years minimum (For example, breast cancer or oral cavity cancer)\n* Previous systemic chemotherapy for current cervical cancer, take into account that prior chemotherapy for a different cancer is accepted, as long as they have been at least 3 years\n* Severe active or non-controlled co-morbidities, defined as:\n* Unstable angina and/or congestive heart failure that required hospitalization in the last 6 months.\n* Transmural myocardial infarction in the last 6 months.\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the beginning of the study.\n* Chronic obstructive pulmonary disease exacerbation or another respiratory disease that requires hospitalization or that contraindicates the trial therapy at the time of admission.\n* Crohn's disease or ulcerative colitis.\n* Prior allergic reaction to cisplatin or other drugs based on platinum.\n* Other factors that contraindicate experimental therapy.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Women over 18 years old",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "over 18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Cervical Cancer at IIIA, IIIB y IIIC1 FIGO´s clinical stages",
"criterions": [
{
"exact_snippets": "Cervical Cancer",
"criterion": "cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "IIIA, IIIB y IIIC1 FIGO´s clinical stages",
"criterion": "FIGO clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"IIIA",
"IIIB",
"IIIC1"
]
}
]
}
]
},
{
"line": "* Histology: squamous, adenosquamous or adenocarcinoma",
"criterions": [
{
"exact_snippets": "Histology: squamous, adenosquamous or adenocarcinoma",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"squamous",
"adenosquamous",
"adenocarcinoma"
]
}
]
}
]
},
{
"line": "* No previous treatment",
"criterions": [
{
"exact_snippets": "No previous treatment",
"criterion": "previous treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No distance metastases, discard by Positron Emission Tomography (PET)/CT",
"criterions": [
{
"exact_snippets": "No distance metastases",
"criterion": "distance metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "discard by Positron Emission Tomography (PET)/CT",
"criterion": "Positron Emission Tomography (PET)/CT",
"requirements": [
{
"requirement_type": "method of assessment",
"expected_value": "PET/CT"
}
]
}
]
},
{
"line": "* Functional State ECOG (Eastern Cooperative Oncology Group) 0-2",
"criterions": [
{
"exact_snippets": "Functional State ECOG (Eastern Cooperative Oncology Group) 0-2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Complete Blood count obtained at least 14 days before admission to the study with adequate bone marrow function defined as:",
"criterions": [
{
"exact_snippets": "Complete Blood count obtained at least 14 days before admission to the study",
"criterion": "complete blood count",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "at least 14 days before admission to the study"
}
]
},
{
"exact_snippets": "adequate bone marrow function",
"criterion": "bone marrow function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Absolute neutrophil count ≥ 1,500 cell/mm3",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count ≥ 1,500 cell/mm3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "cell/mm3"
}
}
]
}
]
},
{
"line": "* Platelets ≥ 100,000 cell/mm3",
"criterions": [
{
"exact_snippets": "Platelets ≥ 100,000 cell/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "cell/mm3"
}
}
]
}
]
},
{
"line": "* Hemoglobin ≥ 10.0 g/dl",
"criterions": [
{
"exact_snippets": "Hemoglobin ≥ 10.0 g/dl",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 10.0,
"unit": "g/dl"
}
}
]
}
]
},
{
"line": "* Leukocyte count ≥ 4000 cell/mm3",
"criterions": [
{
"exact_snippets": "Leukocyte count ≥ 4000 cell/mm3",
"criterion": "leukocyte count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 4000,
"unit": "cell/mm3"
}
}
]
}
]
},
{
"line": "* Adequate Renal Function defined as:",
"criterions": [
{
"exact_snippets": "Adequate Renal Function",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Serum Creatinine ≤ 1.5 mg/dl within 14 days before admission to the study",
"criterions": [
{
"exact_snippets": "Serum Creatinine ≤ 1.5 mg/dl",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "mg/dl"
}
}
]
},
{
"exact_snippets": "within 14 days before admission to the study",
"criterion": "timeframe for serum creatinine measurement",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within 14 days before admission to the study"
}
]
}
]
},
{
"line": "* Patients with HIV infection (human immunodeficiency virus) must have a CD4 cell count ≥ 350 cells / mm3 measured within 14 days prior to study entry (no HIV test is required)",
"criterions": [
{
"exact_snippets": "Patients with HIV infection (human immunodeficiency virus)",
"criterion": "HIV infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "must have a CD4 cell count ≥ 350 cells / mm3",
"criterion": "CD4 cell count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 350,
"unit": "cells / mm3"
}
}
]
},
{
"exact_snippets": "measured within 14 days prior to study entry",
"criterion": "CD4 cell count measurement timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "within 14 days prior to study entry"
}
]
}
]
},
{
"line": "* The patient must understand the protocol and provide the specific informed consent of the study before admission",
"criterions": [
{
"exact_snippets": "The patient must understand the protocol",
"criterion": "understanding of the protocol",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "provide the specific informed consent of the study",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Negative pregnancy test",
"criterions": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients who had chemotherapeutic, surgical and/or radiotherapy treatment for female reproductive tract pathologies",
"criterions": [
{
"exact_snippets": "chemotherapeutic ... treatment for female reproductive tract pathologies",
"criterion": "chemotherapy treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "surgical ... treatment for female reproductive tract pathologies",
"criterion": "surgical treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "radiotherapy treatment for female reproductive tract pathologies",
"criterion": "radiotherapy treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "female reproductive tract pathologies",
"criterion": "female reproductive tract pathologies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous invasive neoplasia (except non-melanoma skin cancer) unless there is complete remission of the disease of 3 years minimum (For example, breast cancer or oral cavity cancer)",
"criterions": [
{
"exact_snippets": "Previous invasive neoplasia (except non-melanoma skin cancer)",
"criterion": "previous invasive neoplasia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "complete remission of the disease of 3 years minimum",
"criterion": "remission duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Previous systemic chemotherapy for current cervical cancer, take into account that prior chemotherapy for a different cancer is accepted, as long as they have been at least 3 years",
"criterions": [
{
"exact_snippets": "Previous systemic chemotherapy for current cervical cancer",
"criterion": "previous systemic chemotherapy",
"requirements": [
{
"requirement_type": "cancer type",
"expected_value": "current cervical cancer"
}
]
},
{
"exact_snippets": "prior chemotherapy for a different cancer is accepted",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "cancer type",
"expected_value": "different cancer"
}
]
},
{
"exact_snippets": "as long as they have been at least 3 years",
"criterion": "time since prior chemotherapy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Severe active or non-controlled co-morbidities, defined as:",
"criterions": [
{
"exact_snippets": "Severe active or non-controlled co-morbidities",
"criterion": "co-morbidities",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": false
}
]
}
]
},
{
"line": "* Unstable angina and/or congestive heart failure that required hospitalization in the last 6 months.",
"criterions": [
{
"exact_snippets": "Unstable angina",
"criterion": "unstable angina",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "congestive heart failure",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "required hospitalization in the last 6 months",
"criterion": "hospitalization",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "last 6 months"
}
]
}
]
},
{
"line": "* Transmural myocardial infarction in the last 6 months.",
"criterions": [
{
"exact_snippets": "Transmural myocardial infarction in the last 6 months.",
"criterion": "transmural myocardial infarction",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Acute bacterial or fungal infection requiring intravenous antibiotics at the beginning of the study.",
"criterions": [
{
"exact_snippets": "Acute bacterial or fungal infection",
"criterion": "infection type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"bacterial",
"fungal"
]
}
]
},
{
"exact_snippets": "requiring intravenous antibiotics",
"criterion": "antibiotic treatment",
"requirements": [
{
"requirement_type": "method",
"expected_value": "intravenous"
}
]
},
{
"exact_snippets": "at the beginning of the study",
"criterion": "timing of infection",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "beginning of the study"
}
]
}
]
},
{
"line": "* Chronic obstructive pulmonary disease exacerbation or another respiratory disease that requires hospitalization or that contraindicates the trial therapy at the time of admission.",
"criterions": [
{
"exact_snippets": "Chronic obstructive pulmonary disease exacerbation",
"criterion": "chronic obstructive pulmonary disease exacerbation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "another respiratory disease that requires hospitalization",
"criterion": "respiratory disease requiring hospitalization",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "respiratory disease ... that contraindicates the trial therapy",
"criterion": "respiratory disease contraindicating trial therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Crohn's disease or ulcerative colitis.",
"criterions": [
{
"exact_snippets": "Crohn's disease",
"criterion": "Crohn's disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "ulcerative colitis",
"criterion": "ulcerative colitis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Prior allergic reaction to cisplatin or other drugs based on platinum.",
"criterions": [
{
"exact_snippets": "Prior allergic reaction to cisplatin",
"criterion": "allergic reaction to cisplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "allergic reaction to ... other drugs based on platinum",
"criterion": "allergic reaction to platinum-based drugs",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Other factors that contraindicate experimental therapy.",
"criterions": [
{
"exact_snippets": "factors that contraindicate experimental therapy",
"criterion": "contraindicating factors for experimental therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}